StonvexLoading…
StonvexStonvexStonvexCore line items from RES's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2018 2018-12-31 | Annual 2017 2017-12-31 | Annual 2016 2016-12-31 |
|---|---|---|---|
Revenue | $1.72B | $1.60B | $728.97M |
Operating Income | $210.03M | $226.22M | $-238.94M |
Net Income | $175.40M | $162.51M | $-141.25M |
EPS (Diluted) | $0.82 | $0.75 | $-0.66 |
Total Assets | $1.20B | $1.15B | $1.04B |
Total Liabilities | $249.16M | $235.53M | $228.65M |
Cash & Equivalents | $116.26M | $91.05M | $131.84M |
Free Cash Flow OCF − CapEx | $146.40M | $16.20M | $67.77M |
Shares Outstanding | 214.54M | 216.54M | 217.49M |